Insulet Basic EPS 2010-2025 | PODD
Insulet annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Insulet basic eps for the quarter ending June 30, 2025 was $0.32, a 88.1% decline year-over-year.
- Insulet basic eps for the twelve months ending June 30, 2025 was $3.36, a 40.64% decline year-over-year.
- Insulet annual basic eps for 2024 was $0.006B, a 101.69% increase from 2023.
- Insulet annual basic eps for 2023 was $0.003B, a 4128.57% increase from 2022.
- Insulet annual basic eps for 2022 was $0B, a 72% decline from 2021.
| Insulet Annual Basic EPS | |
|---|---|
| 2024 | $5.97 |
| 2023 | $2.96 |
| 2022 | $0.07 |
| 2021 | $0.25 |
| 2020 | $0.11 |
| 2019 | $0.19 |
| 2018 | $0.06 |
| 2017 | $-0.46 |
| 2016 | $-0.48 |
| 2015 | $-1.29 |
| 2014 | $-0.92 |
| 2013 | $-0.83 |
| 2012 | $-1.08 |
| 2011 | $-0.98 |
| 2010 | $-1.54 |
| 2009 | $-2.43 |
| Insulet Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $0.32 |
| 2025-03-31 | $0.50 |
| 2024-12-31 | $1.43 |
| 2024-09-30 | $1.11 |
| 2024-06-30 | $2.69 |
| 2024-03-31 | $0.74 |
| 2023-12-31 | $1.49 |
| 2023-09-30 | $0.74 |
| 2023-06-30 | $0.39 |
| 2023-03-31 | $0.34 |
| 2022-12-31 | $0.25 |
| 2022-09-30 | $-0.08 |
| 2022-06-30 | $-0.50 |
| 2022-03-31 | $0.40 |
| 2021-12-31 | $0.44 |
| 2021-09-30 | $0.18 |
| 2021-06-30 | $-0.37 |
| 2021-03-31 | |
| 2020-12-31 | $-0.26 |
| 2020-09-30 | $0.18 |
| 2020-06-30 | $0.22 |
| 2020-03-31 | $-0.03 |
| 2019-12-31 | $0.09 |
| 2019-09-30 | $0.01 |
| 2019-06-30 | $0.02 |
| 2019-03-31 | $0.07 |
| 2018-12-31 | $0.17 |
| 2018-09-30 | $0.03 |
| 2018-06-30 | $-0.03 |
| 2018-03-31 | $-0.11 |
| 2017-12-31 | $-0.12 |
| 2017-09-30 | $-0.04 |
| 2017-06-30 | $-0.13 |
| 2017-03-31 | $-0.17 |
| 2016-12-31 | $-0.13 |
| 2016-09-30 | $-0.05 |
| 2016-06-30 | $-0.08 |
| 2016-03-31 | $-0.22 |
| 2015-12-31 | $-0.47 |
| 2015-09-30 | $-0.34 |
| 2015-06-30 | $-0.27 |
| 2015-03-31 | $-0.21 |
| 2014-12-31 | $-0.09 |
| 2014-09-30 | $-0.19 |
| 2014-06-30 | $-0.53 |
| 2014-03-31 | $-0.11 |
| 2013-12-31 | $-0.04 |
| 2013-09-30 | $-0.39 |
| 2013-06-30 | $-0.20 |
| 2013-03-31 | $-0.20 |
| 2012-12-31 | $-0.21 |
| 2012-09-30 | $-0.26 |
| 2012-06-30 | $-0.30 |
| 2012-03-31 | $-0.31 |
| 2011-12-31 | $-0.30 |
| 2011-09-30 | $-0.29 |
| 2011-06-30 | $-0.17 |
| 2011-03-31 | $-0.22 |
| 2010-12-31 | $-0.50 |
| 2010-09-30 | $-0.30 |
| 2010-06-30 | $-0.36 |
| 2010-03-31 | $-0.38 |
| 2009-12-31 | $-0.39 |
| 2009-09-30 | $-0.60 |
| 2009-06-30 | $-0.73 |
| 2009-03-31 | $-0.71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.742B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |